6 suspended. 6 Phase 2, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 6 | Suspended 6 |
| Phase 3 | 2 | Suspended 2 |
Follow Inflammation: new trials by email Literature Review of Inflammation trials Research Report on Inflammation
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy of Para-Tyrosine Supplementation on the Survival and Clinical Outcome in Patients With Sepsis Para-Tyrosine supplementation, Placebo solution - Sepsis | Phase 2 | Suspended | University of Pecs | 296 | 2027-01-01 | 2025-03-30 |
| Mild-Intensity Whole Body Hyperthermia (WBH) for Major Depressive Disorder Tocilizumab, Placebo, Whole-Body Hyperthermia - Major Depressive Disorder | Phase 2 | Suspended | Massachusetts General Hospital | 35 | 2026-12-01 | 2025-11-13 |
| Reducing Frailty for Older Cancer Survivors Using Supplements II Epigallocatechin-3-Gallate (EGCG), Microcrystalline cellulose (MCC), Ascorbic Acid (Vitamin C) - Frailty, Inflammation | Phase 2 | Suspended | University of Rochester | 118 | 2024-10-25 | 2026-06-26 |
| Hemodynamics Effects of Fludrocortisone on the Pressor Response to Noradrenaline Septic Shock Patients Fludrocortisone, Placebo - Septic Shock | Phase 2 / Phase 3 | Suspended | Rennes University Hospital | 40 | 2022-03-31 | 2023-11-18 |
| Inflammation and Stem Cells in Diabetic and Chronic Kidney Disease Fisetin, Placebo oral capsule - Chronic Kidney Diseases, Diabetes Mellitus | Phase 2 | Suspended | Mayo Clinic | 30 | 2018-01-02 | 2026-01-28 |
| Safety and Efficacy of Talactoferrin Alfa in Patients With Severe Sepsis Talactoferrin alfa, Placebo - Severe Sepsis | Phase 2 / Phase 3 | Suspended | Agennix | 1280 | 2011-06-01 | 2012-02-03 |
Frailty (2) · Sepsis (2) · Depression (1) · Depressive Disorder, Major (1) · Diabetes Mellitus (1) · Diabetic Nephropathies (1) · Hyperthermia (1) · Renal Insufficiency, Chronic (1) · Shock, Septic (1)
Pathologic Processes (6) · Pathological Conditions, Signs and Symptoms (6) · Infections (3) · Systemic Inflammatory Response Syndrome (3) · Behavior (1) · Behavioral Symptoms (1) · Body Temperature Changes (1) · Chronic Disease (1) · Depressive Disorder (1) · Diabetes Complications (1) · Disease Attributes (1) · Endocrine System Diseases (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1)
Ascorbic Acid (1) · Fludrocortisone (1) · Sodium Chloride (1) · epigallocatechin gallate (1) · fisetin (1) · microcrystalline cellulose (1) · talactoferrin alfa (1) · tocilizumab (1)
Agennix (1) · Massachusetts General Hospital (1) · Mayo Clinic (1) · Rennes University Hospital (1) · University of Pecs (1) · University of Rochester (1)
United States (4) · France (2) · Belgium (1) · Canada (1) · Denmark (1) · Germany (1) · Hungary (1) · Israel (1) · Netherlands (1) · Spain (1) · United Kingdom (1)
Bruno Laviolle, MD, PhD (1) · Harmonie Perrichet, MD (1) · LaTonya J Hickson, MD (1)